Volitionrx (VNRX) Research & Development (2019 - 2025)
Historic Research & Development for Volitionrx (VNRX) over the last 9 years, with Q3 2025 value amounting to $2.3 million.
- Volitionrx's Research & Development fell 3419.54% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.2 million, marking a year-over-year decrease of 3765.85%. This contributed to the annual value of $14.4 million for FY2024, which is 2631.53% down from last year.
- Volitionrx's Research & Development amounted to $2.3 million in Q3 2025, which was down 3419.54% from $2.7 million recorded in Q2 2025.
- Volitionrx's Research & Development's 5-year high stood at $5.5 million during Q2 2023, with a 5-year trough of $2.3 million in Q3 2025.
- In the last 5 years, Volitionrx's Research & Development had a median value of $3.6 million in 2021 and averaged $3.7 million.
- Per our database at Business Quant, Volitionrx's Research & Development skyrocketed by 6623.21% in 2023 and then crashed by 4367.8% in 2025.
- Over the past 5 years, Volitionrx's Research & Development (Quarter) stood at $3.3 million in 2021, then rose by 25.18% to $4.1 million in 2022, then rose by 10.02% to $4.5 million in 2023, then tumbled by 43.06% to $2.6 million in 2024, then dropped by 11.65% to $2.3 million in 2025.
- Its Research & Development was $2.3 million in Q3 2025, compared to $2.7 million in Q2 2025 and $2.6 million in Q1 2025.